Catalyst Wire Dossier Catalyst Wire Dossier

Sotrovimab (Xevudy)

sotrovimab · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sotrovimab (Xevudy), covering 2024-06-07 to 2024-06-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian Participants [Phase 1]

See pricing